STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Company

ENANTA PHARMACEUTICALS INC

Filed

March 7, 2022

Period of Report

March 3, 2022

Accession Number

0001062993-22-007011